Myriad Genetics | MYGN - Loan Capital


Myriad Genetics reported $120.3M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Agilent USD 3.05B 1000K Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Bio-Rad Laboratories USD 802.9M 398.8M Mar/2026
Bruker USD 1.66B 189.6M Mar/2026
Danaher USD 17.56B 855M Mar/2026
Illumina USD 1.49B 0 Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Mettler Toledo International USD 2.16B 73.35M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quest Diagnostics USD 5.16B 12M Mar/2026
Quidel USD 0 2.47B Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Standard Biotools USD 299K 0 Mar/2026
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.22B 3.81B Mar/2026